Keywords: factor V Leiden mutation; hypercoagulable state; hyperhomocysteinemia; livedoid vasculopathy; protein C deficiency; protein S deficiency; thrombophilia; thrombosis; ulcers; warfarin necrosis; AB; atrophie blanche; APC; activated protein C; APS; antiphosph